Dr. Tomas Neilan discusses cardiotoxicity of novel immunotherapies, focusing on immune checkpoint inhibitors and their adverse cardiac effects. Topics include diagnosis, treatment, and challenges of ICI-related myocarditis, emphasizing the importance of baseline assessments and prompt recognition. The episode also touches on subclinical myocarditis, management strategies, and the impact of corticosteroids on cancer outcomes.